Myeloid patients respond robustly to Moderna COVID vaccineDecember 12, 2021COVID-19 UpdatesHematology
For leukemias, COVID-19 death risks tied to poor prognoses, ICU deferralsDecember 11, 2021COVID-19 UpdatesCritical CareHematology
Bullying a ‘persistent, important’ problem for cardiology traineesDecember 10, 2021Business of Medicine
Ongoing HER2 breast cancer therapy may cost an additional $68,000 per patientDecember 10, 2021Oncology
FDA authorizes Pfizer boosters for 16- and 17-year-oldsDecember 9, 2021COVID-19 UpdatesVaccinesPediatrics
Medical board stops warning docs against giving false COVID informationDecember 9, 2021COVID-19 Updates
AMA, hospital group sue federal government over surprise billing lawDecember 9, 2021Business of Medicine
Risk for severe COVID-19 and death plummets with Pfizer boosterDecember 9, 2021COVID-19 UpdatesPreventive CarePulmonologyInfectious DiseasesVaccines
